Cost-effectiveness of Paxlovid in reducing severe COVID-19 and mortality in China.

Front Public Health · 2023 · PMC10315619 · PMID 37404282

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

An overall trend of an increasing cost-effectiveness probability of the Paxlovid cohort was observed with the price of Paxlovid/box decreased.

also in 1,675 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.